DIFFERENTIAL ANTIBODY-RESPONSES TO AG-B (A-REGION) AND IA (B-REGION) ANTIGENS DURING ENHANCEMENT OF RAT RENAL-ALLOGRAFTS

被引:21
作者
SUTHANTHIRAN, M
CATTO, GRD
KALDANY, A
GEORGE, K
GAROVOY, MR
STROM, TB
CARPENTER, CB
机构
[1] PETER BENT BRIGHAM HOSP,IMMUNOL LAB,BOSTON,MA 02115
[2] PETER BENT BRIGHAM HOSP,DEPT MED,DIV RENAL,HOWARD HUGHES MED INST LAB,BOSTON,MA 02115
关键词
D O I
10.1097/00007890-197907000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rat renal allograft survival may be enhanced by active preimmunization, or by passive transfer of antidonor antibodies. In the (LEW X BN)F 1 to LEW X LEW model, antibodies to Ia-like (B region) antigens, but not Ag-B (A region) antigens promote passive enhancement. Serum antibody responses to Ia and Ag-B antigens were assessed serially in passively enhanced animals to see whether there were similar quantitative and qualitative suppressions of the immune response, as compared to unmodified rejecting controls. Acid eluates from homogenized allografts were also studied and compared to serum activities. Rejecting animals produced antibodies to both Ag-B and la gene products, rising sharply between days 4 and 7 after transplantation. Passively enhanced recipients made no detectable anti-Ia, and very weak anti-Ag-B, responses. Active immunization with cells produced anti-Ag-B and anti-Ia responses 1 week later; after transplantation there was disappearance of serum anti-Ag-B and some reduction in anti-Ia levels. When graft eluates were prepared 7 days after transplantation, passively enhanced kidneys had only traces of antibody activity, while actively enhanced kidneys had anti-Ag-B, but no anti-Ia, compared to controls in which both types of antibodies were readily recovered. Hence, antibody responses to gene products of different regions of the rat major histocompatibility complex (MHC) are not identical in states of rejection, passive, or active enhancement. © 1979 by The Williams & Wilkins Co.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 31 条
[1]  
ABBAS AK, 1974, AM J PATHOL, V75, P255
[2]  
ABBAS AK, 1974, AM J PATHOL, V75, P275
[3]   CELLULAR AND HUMORAL IMMUNITY AFTER ALLOGENEIC TRANSPLANTATION IN RAT .2. COMPARISON OF A CR-51 RELEASE ASSAY AND MODIFIED MICROCYTOTOXICITY ASSAY FOR DETECTION OF CELLULAR IMMUNITY AND BLOCKING SERUM FACTORS [J].
BIESECKER, JL ;
FITCH, FW ;
ROWLEY, DA ;
SCOLLARD, D ;
STUART, FP .
TRANSPLANTATION, 1973, 16 (05) :421-431
[4]   QUANTITATIVE STUDIES ON TISSUE TRANSPLANTATION IMMUNITY .2. THE ORIGIN, STRENGTH AND DURATION OF ACTIVELY AND ADOPTIVELY ACQUIRED IMMUNITY [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1954, 143 (910) :58-80
[5]   HUMORAL AND CELL-MEDIATED-IMMUNITY IN RATS WITH ENHANCED KIDNEY ALLOGRAFTS [J].
BURGOS, H ;
FRENCH, ME ;
BATCHELOR, JR .
TRANSPLANTATION, 1974, 18 (04) :328-335
[6]  
BUTCHER GW, 1977, RAT NEWSLETTER, V2, P9
[7]  
CATTO GRD, 1977, TRANSPLANT P, V9, P957
[8]   WHAT ABROGATES HEART-TRANSPLANT REJECTION IN IMMUNOLOGICAL ENHANCEMENT [J].
DAVIES, DAL ;
ALKINS, BJ .
NATURE, 1974, 247 (5439) :294-297
[9]  
DAVIES DAL, 1976, TRANSPLANT REV, V30, P18
[10]   AG-F - SEROLOGICAL AND GENETIC IDENTIFICATION OF A NEW LOCUS IN RAT GOVERNING LYMPHOCYTE MEMBRANE ANTIGENS [J].
DEWITT, CW ;
MCCULLOUGH, M .
TRANSPLANTATION, 1975, 19 (04) :310-317